MedTrace Logo

Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC

NCT02429310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2020-10-08

Study results available
· View outcomes & findings →

Summary

This study will assess the adjuvant benefit of a neuromuscular electrical stimulation device to standard treatment of supervised exercise in patients suffering from symptoms and effects of lower limb Intermittent Claudication.

Conditions

  • Intermittent Claudication
  • Peripheral Vascular Disease
  • Lower Limb Arterial Disease

Interventions

DEVICE

Revitive IX

This is a neuromuscular electrical stimulation device

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alun H Davies, MA FRCS DM · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429310 on ClinicalTrials.gov